North America Nucleic Acid Isolation Purification Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
USD
3.46 Billion
USD
7.65 Billion
2024
2032
 예측 기간 |
2025 –2032 |
 시장 규모(기준 연도) |
USD 3.46 Billion |
 시장 규모(예측 연도) |
USD 7.65 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
북미 핵산 분리 및 정제 시장, 제품별(기기, 키트 및 시약), 방법(자기 비드 기반 분리 및 정제, 컬럼 기반 분리 및 정제, 시약 기반 분리 및 정제 및 기타), 유형(차세대 시퀀싱(NGS), 게놈 DNA 분리 및 정제, 총 RNA 분리 및 정제, PCR 정제, 플라스미드 DNA 분리 및 정제, 메신저 RNA 분리 및 정제, 순환 핵산 분리 및 정제, 마이크로RNA 분리 및 정제 및 기타), 응용 분야(진단, 약물 발견 및 개발, 개인 맞춤 의학, 농업 및 동물 연구, 기타), 샘플 유형(FFPE 샘플, 혈액 세포, 박테리아, 효모 및 식물, 무세포 샘플, 배양 세포, 포유류 세포 및 뇌 및 신장 조직 및 기타), 최종 사용자(병원 및 진단 센터, 제약 및 생명공학 회사, 계약 연구 기관, 계약 개발 및 제조 기관(CDMO), 학계/연구 기관 및 기타) 2032년까지의 산업 동향 및 예측
핵산 분리 및 정제 시장 규모
- 북미 핵산 분리 및 정제 시장은 2024년에 34억 6천만 달러 규모로 평가되었으며 2032년에는 76억 5천만 달러 에 이를 것으로 예상됩니다.
- 2025년부터 2032년까지의 예측 기간 동안 시장은 주로 새로운 치료 장치 출시 예상에 따라 11.0%의 CAGR로 성장할 것으로 예상됩니다.
- 이러한 성장은 특히 개발도상국에서 유전 질환의 유병률 증가와 같은 요인에 의해 촉진되며 진단 테스트에 대한 수요 증가를 촉진합니다.
핵산 분리 및 정제 분석
- 핵산 기반 진단, 개인 맞춤 의학 및 생물 약제학 연구에 대한 수요 증가로 인해 효율적인 핵산 분리 및 정제 기술에 대한 필요성이 크게 증가했습니다.
- 또한 자동화, 자기 비드 기반 분리 및 미세유체 플랫폼의 발전으로 핵산 추출 속도, 수율 및 정확도가 향상되어 임상 및 연구 환경에서 고처리량 응용 프로그램을 지원합니다.
- 예를 들어, 핵산 분리 및 정제 시장은 생명공학 부문의 확대와 R&D 자금 증가로 기술 도입이 가속화되고 있는 아시아 태평양 지역과 같은 지역에서 눈에 띄는 성장을 보이고 있습니다.
- 결론적으로, 성장하는 응용 분야와 분리 기술의 지속적인 혁신의 융합은 강력한 시장 확장을 촉진하여 전 세계적으로 분자 진단, 약물 발견 및 게놈 연구를 개선하고 있습니다.
보고서 범위 및 핵산 분리 및 정제 세분화
|
속성 |
핵산 분리 및 정제 주요 시장 통찰력 |
|
다루는 세그먼트 |
|
|
포함 국가 |
|
|
주요 시장 참여자 |
|
|
시장 기회 |
|
|
부가가치 데이터 정보 세트 |
Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다. |
핵산 분리 및 정제 시장 동향
"비침습적 진단 분야에서 액체 생검의 적용 확대"
- 혈액 등 체액에 존재하는 순환 핵산(DNA, RNA, 엑소좀)을 분석하는 액체 생검을 통해 다양한 질병, 특히 암을 조기에 발견하고 모니터링하며 개인 맞춤형 치료를 제공할 수 있습니다.
- 다양하고 종종 단편화된 샘플에서 고품질 핵산을 추출하는 데에는 복잡한 기술이 필요하므로 고급 분리 및 정제 기술이 필요합니다.
- 예를 들어 , 고처리량 오믹스 기술과 결합된 액체 생검은 비침습적 개인 맞춤형 진단을 통해 질병 관리를 혁신하고 있습니다. 다양한 생체 유체로의 사용 확대와 임상 실무 통합은 액체 생검의 유용성을 더욱 부각합니다. 표준화, 프로토콜 개선, 그리고 바이오마커 발견은 핵산 정제 기술의 발전을 촉진하여 더욱 정확하고 접근성이 높으며 개인 맞춤형 환자 치료를 가능하게 합니다.
- 비침습적 진단 도구로서 액체 생검의 등장은 핵산 분리 및 정제 시장에 상당한 기회를 제공합니다.
- 액체 생검이 질병의 조기 발견 및 치료 모니터링에 점점 더 많이 사용됨에 따라, 복잡한 생물학적 유체에서 고품질 핵산을 추출할 수 있는 고급 정제 기술에 대한 필요성이 커지고 있습니다.
핵산 분리 및 정제 시장 동향
운전사
“게놈학 연구에 대한 투자 증가”
- 전 세계 정부, 민간 부문, 연구 기관으로부터 자금이 유입되면서 대규모 시퀀싱 프로젝트, 유전자 편집, 바이오마커 발견, 개인 맞춤 의료 이니셔티브를 지원하기 위해 안정적이고 고품질의 핵산 분리에 대한 필요성이 커졌습니다.
- 이 투자는 CRISPR, 차세대 시퀀싱(NGS) 및 기타 게놈 도구와 같은 고급 응용 프로그램에 필요한 품질을 DNA 및 RNA 샘플이 충족하도록 보장하는 효율적이고 정확한 정제 시스템에 대한 수요를 증가시킵니다.
- 연구가 확대됨에 따라 확장 가능하고 처리량이 높은 분리 방법에 대한 요구 사항도 늘어나 시장 성장이 강화되고 핵산 정제 기술 혁신이 촉진됩니다.
예를 들어,
- BMJ에 따르면, 2022년 12월, 정부는 3개년 계획의 일환으로 신생아 희귀 유전 질환 진단 개선, 암 진단 개선, 그리고 건강 불평등 해소에 1억 9,054만 달러 이상을 투자할 계획이었습니다. 투자가 증가함에 따라, 이 분야에서는 시장 성장을 견인하는 새로운 혁신 기술들이 등장하고 있습니다.
- NHGRI에 따르면, 2023년 9월, 미국 국립 인간 유전체 연구소(NHGRI)는 정부, 공공 및 민간 기관의 과학자들과 협력하고 자금을 지원함으로써 유전체학 연구를 가속화합니다. All of Us Research Program 및 ENCODE와 같은 이니셔티브를 통해 NHGRI는 유전적 변이와 그 변이가 건강에 미치는 영향에 대한 연구를 지원합니다. 파트너십은 시퀀싱 및 데이터 분석 기술 발전, 유전체학 도구 개선 및 지식 공유로까지 확대됩니다. 이러한 협력적 접근 방식은 정밀 의학 및 공중 보건 분야의 획기적인 발전을 촉진하는 것을 목표로 합니다.
- 게놈학 연구에 대한 투자 증가로 인해 더 많은 자금이 고급 유전학 연구와 표적 치료법 개발을 지원함에 따라 핵산 분리 및 정제 시장이 촉진됩니다.
- NGS 및 CRISPR과 같은 확장된 응용 프로그램과 함께 고품질 DNA 및 RNA 정제에 대한 수요가 증가함에 따라 최첨단 유전체학을 지원하는 확장 가능하고 효율적인 분리 솔루션에 대한 필요성이 생겨났습니다.
기회
“기술 발전과 자동화의 증가”
- 완전 자동화된 추출 시스템, 고처리량 시퀀싱, 미세유체공학과 같은 기술 혁신은 유전 연구 및 진단의 정확성, 속도 및 확장성을 향상시키고 있습니다.
- 이러한 발전은 수동 개입을 줄임으로써 인적 오류를 최소화하고 샘플 처리의 일관성을 향상시킵니다. 실험실에서 대용량 샘플을 정밀하고 효율적으로 처리할 수 있도록 지원함으로써 유전체학, 단백질체학, 그리고 개인 맞춤 의학 분야의 증가하는 수요를 충족합니다.
예를 들어,
- 테크놀로지 네트워크(Technology Networks)에 따르면, 과학 서비스 분야의 글로벌 리더인 Thermo Fisher Scientific Inc.는 2023년 12월, 자동 핵산 정제 장비인 Thermo Scientific KingFisher Apex Dx와 Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit를 출시했습니다. 이 제품들은 호흡기 검체에서 바이러스 및 박테리아 병원균을 분리하고 정제하는 데 사용됩니다. 체외 진단(IVD) 및 체외 진단 규정(IVD-R)을 준수하도록 설계된 이 자동화 솔루션은 실험실의 후속 검사 결과에 대한 신뢰성을 높여줍니다.
- 2023년 11월, 엘스비어(Elsevier)는 감염성 질환 진단을 위한 RNA/DNA 자동 추출 및 정제 장치 개발이 생명공학의 중추적인 발전을 의미하며, 이 분야의 기술 혁신과 자동화 증가를 강조했습니다. 이러한 장치는 복잡한 실험실 워크플로우를 간소화하여 신속하고 정밀한 샘플 처리를 가능하게 하는데, 이는 특히 질병 발생 시 정확한 진단에 필수적입니다. 기술 발전으로 더욱 컴팩트하고 효율적이며 사용자 친화적인 시스템이 구축되어 수동 개입을 줄이고 처리량과 신뢰성을 향상시켰습니다. 자동화는 오류를 최소화할 뿐만 아니라 진단 프로세스 속도를 높여 시기적절한 임상 결정을 지원하고 환자 결과를 개선합니다. 이러한 첨단 기술의 통합은 진단을 혁신하여 다양한 의료 환경에 대한 접근성, 확장성, 적응성을 향상시키고 있습니다.
- 기술과 자동화의 급속한 발전은 정확도, 효율성 및 다운스트림 프로세스와의 통합을 향상시켜 핵산 분리 및 정제 시장을 변화시키고 있습니다.
- 이러한 혁신을 통해 실험실은 유전체학, 진단, 그리고 개인 맞춤 의학 분야에서 증가하는 수요를 처리량 증가와 비용 절감으로 충족할 수 있습니다. 이러한 기술들이 더욱 널리 보급됨에 따라 연구 및 진단 역량이 확장되어 전 세계 실험실과 기관에서 더 폭넓게 도입되고, 궁극적으로 다양한 과학 및 의학 분야의 발전을 가속화합니다.
제지/도전
“다양한 샘플 유형에 따른 핵산 분리의 기술적 어려움”
- 혈액, 조직, 소변, 타액과 같은 다양한 샘플 소스는 핵산 농도의 다양한 수준, 억제제의 존재 및 생물학적 매트릭스의 복잡성으로 인해 고유한 과제를 제시합니다.
- 혈액 샘플에는 순환하는 자유 DNA 또는 RNA가 소량 포함될 수 있지만 조직 샘플은 핵산 추출을 방해하는 오염 물질과 세포 구성 요소의 수준이 높아서 더 어려울 수 있습니다.
- 또한 포르말린 고정 파라핀 포매 조직과 같은 특정 샘플은 분리 과정 중 핵산의 분해 또는 손실을 방지하기 위해 특수한 방법이 필요합니다.
예를 들어,
- In September 2020, article published by APOS stated, biological samples such as saliva or urine contain low concentrations of nucleic acids, requiring highly sensitive protocols to ensure accurate extraction. Tissues, particularly those with high levels of proteins or lipids, often present obstacles in separating pure nucleic acids without contamination. Also, samples like FFPE tissues are subjected to formalin fixation, which cross-links nucleic acids and makes extraction more difficult. However, overcoming the inherent complexities of different sample types remains a critical focus for future developments, ensuring that nucleic acid extraction and isolation methods are adaptable, efficient, and scalable for a broad range of clinical and research applications
- In September 2020,as per Complex sample matrices often contain inhibitors that interfere with nucleic acid amplification, reducing test sensitivity and reliability. Effective lysis and extraction methods must avoid these inhibitors while remaining compatible with simplified workflows. Balancing performance with portability is essential for adapting nucleic acid purification processes to field-ready, point-of-need diagnostic platforms
- Technical challenges in isolating nucleic acids from various sample types, such as blood, tissue, and urine, create obstacles in the nucleic acid purification market
- These samples often present low nucleic acid yields, inhibitors, or complex biological matrices, requiring specialized methods for effective extraction
North America Nucleic Acid Isolation and Purification Market Scope
North America nucleic acid isolation and purification market is categorized into five notable segments the basis of product, method, type, sample type, and end user.
|
Segmentation |
Sub-Segmentation |
|
BY PRODUCT |
|
|
BY METHOD |
|
|
BY TYPE |
|
|
BY SAMPLE TYPE |
|
|
BY END USER |
|
U.S. Nucleic Acid Isolation and Purification Market Regional Analysis
“U.S. is the Dominant region in the Nucleic Acid Isolation and Purification Market”
- U.S. is the dominant country in the nucleic acid isolation and purification market due to its well-established biotechnology and pharmaceutical industries, along with high investment in genomic research and precision medicine
- Furthermore, the presence of major market players, robust healthcare infrastructure, and increasing demand for molecular diagnostics contribute to the U.S. market leadership
- Additionally, strong government funding for research initiatives and widespread adoption of advanced automation technologies further enhance U.S.’s position in the North America market
“U.S. is Projected to Register the Highest CAGR in Market”
- U.S. is projected to register strong growth in the North America nucleic acid isolation and purification market, driven by expanding biotechnology sectors and increasing investments in life sciences research
- Furthermore, the growing adoption of personalized medicine, rising demand for molecular diagnostics, and a surge in academic and clinical research activities are contributing to market expansion
- Additionally, supportive government initiatives, improving healthcare infrastructure, and the presence of emerging biotech startups are expected to further accelerate the adoption of nucleic acid isolation and purification technologies in the U.S.
Nucleic Acid Isolation and Purification Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Thermo Fisher Scientific Inc. (U.S.)
- Illumina Inc. (U.S.)
- PerkinElmer (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- QIAGEN (Germany)
- Takara Bio Inc. (Japan)
- MACHEREY-NAGEL GmbH & Co. KG (Germany)
- Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Merck KGaA (Germany)
- Cytiva (Danaher Corporation) (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Promega Corporation (U.S.)
- New England Biolabs (U.S.)
- Omega Bio-tek, Inc. (U.S.
- Zymo Research Corporation (U.S.)
Latest Developments in Nucleic Acid Isolation and Purification
- In April 2025 , Analytik Jena has introduced a new 1536-tip tray for the CyBio Well vario, enabling parallel pipetting in 1536 channels with volumes ranging from 100 nL to 8 µL. This innovation, ideal for high-throughput applications, ensures high accuracy, minimal reagent consumption, and supports sustainable, reproducible laboratory workflows
- In March 2024 , Analytik Jena has launched the multi N/C x300 series of TOC/TNb analyzers, offering user-friendly design, flexible automation, and intuitive software. Ideal for environmental and pharmaceutical applications, these analyzers ensure high throughput, reliability, and low operational costs, enabling efficient sample preparation, calibration, and maintenance with pharma-compliant data integrity
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
5 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 REGULATORY SUBMISSIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF GENETIC DISORDERS
6.1.2 INCREASING DEMAND FOR DIAGNOSTIC TESTING
6.1.3 RISING INVESTMENT IN GENOMICS RESEARCH
6.1.4 INCREASE IN LAUNCH OF DIAGNOSTIC PRODUCTS
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH SAMPLE CONTAMINATION
6.2.2 HIGH COST OF EQUIPMENT AND REAGENTS
6.3 OPPORTUNITIES
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS AND AUTOMATION
6.3.2 INCREASING ADOPTION OF NEXT-GENERATION SEQUENCING (NGS)
6.3.3 GROWING APPLICATIONS OF LIQUID BIOPSY IN NON-INVASIVE DIAGNOSTICS
6.4 CHALLENGES
6.4.1 TECHNICAL DIFFICULTIES IN NUCLEIC ACID ISOLATION ACROSS DIFFERENT SAMPLE TYPES
6.4.2 ENVIRONMENTAL AND SUSTAINABILITY CONCERNS
7 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
7.1 OVERVIEW
7.2 NEXT GENERATION SEQUENCING (NGS)
7.3 GENOMIC DNA ISOLATION AND PURIFICATION
7.4 TOTAL RNA ISOLATION AND PURIFICATION
7.5 PCR CLEAN-UP
7.6 PLASMID DNA ISOLATION AND PURIFICATION
7.7 MESSENGER RNA ISOLATION AND PURIFICATION
7.8 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
7.9 MICRORNA ISOLATION AND PURIFICATION
7.1 OTHERS
8 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INSTRUMENTS
8.2.1 HOMOGENIZER
8.2.2 SPECTROPHOTOMETERS
8.2.3 FLUOROMETERS
8.2.4 OTHERS
8.2.4.1 Benchtop
8.2.4.2 Standalone
8.2.4.2.1 Automated
8.2.4.2.2 Manual
8.3 KITS
8.3.1 DNA ISOLATION & PURIFICATION KITS
8.3.2 RNA ISOLATION & PURIFICATION KITS
8.3.3 VIRAL NUCLEIC ACID ISOLATION KITS
8.3.4 PLASMID PURIFICATION KIT
8.3.5 PCR AND GEL KIT
8.3.6 OTHERS
8.3.6.1 MAGNETIC BEAD-BASED KIT
8.3.6.2 COLUMN-BASED KIT
8.3.6.3 REAGENT-BASED KIT
8.3.6.3.1 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT
8.3.6.3.2 PLANT DNA ISOLATION KIT
8.3.6.3.3 CELL-FREE TOTAL NUCLEIC ACID KIT
8.3.6.3.4 CELL-FREE DNA ISOLATION KIT
8.3.7 GENOMIC DNA PURIFICATION KIT
8.3.8 VIRAL RNA/DNA PURIFICATION KIT
8.3.9 PLANT DNA PURIFICATION KIT
8.3.10 MICROBIOME DNA PURIFICATION KIT
8.3.11 OTHERS
8.3.12 MAGNETIC BEAD-BASED KIT
8.3.13 COLUMN-BASED KIT
8.3.14 REAGENT-BASED KIT
8.3.15 VIRAL/PATHOGEN NUCLEIC ACID ISOLATION KIT
8.3.16 MRNA PURIFICATION KIT
8.3.17 PLANT RNA ISOLATION KIT
8.3.18 CELL-FREE NUCLEIC ACID ISOLATION KIT
8.3.19 OTHERS
8.3.20 RNA ISOLATION KIT
8.3.21 MI RNA ISOLATION KIT
8.3.22 VIRAL RNA/DNA KIT
8.3.23 MAGNETIC BEAD-BASED KITS
8.3.24 VIRAL SPIN-COLUMN KITS
8.4 REAGENTS
8.4.1 DNA ISOLATION REAGENT
8.4.2 RNA ISOLATION REAGENT
8.4.3 OTHERS
9 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE
9.1 OVERVIEW
9.2 FFPE SAMPLES
9.3 BLOOD CELLS
9.4 BACTERIA, YEAST, AND PLANTS
9.5 CELL-FREE SAMPLES
9.6 CULTURED CELLS
9.7 MAMMALIAN CELLS
9.8 BRAIN AND KIDNEY TISSUE
9.9 OTHERS
10 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
10.1 OVERVIEW
10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
10.3 COLUMN -BASED ISOLATION AND PURIFICATION
10.4 REAGENT-BASED ISOLATION AND PURIFICATION
10.5 OTHERS
11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 DIAGNOSTICS
11.2.1 INSTRUMENTS
11.2.2 KITS
11.2.3 REAGENTS
11.3 DRUG DISCOVERY AND DEVELOPMENT
11.3.1 INSTRUMENTS
11.3.2 KITS
11.3.3 REAGENTS
11.4 PERSONALIZED MEDICINE
11.4.1 INSTRUMENTS
11.4.2 KITS
11.4.3 REAGENTS
11.5 AGRICULTURE AND ANIMAL RESEARCH
11.5.1 INSTRUMENTS
11.5.2 KITS
11.5.3 REAGENTS
11.6 OTHERS
12 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS AND DIAGNOSTIC CENTERS
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 CONTRACT RESEARCH ORGANIZATIONS
12.5 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
12.6 ACADEMIC/RESEARCH INSTITUTES
12.7 OTHERS
13 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 MERCK KGAA
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 CYTIVA (DANAHER CORPORATION)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 AGILENT TECHNOLOGIES, INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 BIO-RAD LABORATORIES, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 F. HOFFMANN-LA ROCHE LTD
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ANALYTIK JENA GMBH+CO. KG
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 AUTOGEN, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 DAAN GENE CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 HIMEDIA LABORATORIES
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 ILLUMINA, INC.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 KURABO INDUSTRIES LTD.
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 PRODUCT PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 LGC BIOSEARCH TECHNOLOGIES
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 MACHEREY-NAGEL GMBH & CO. KG
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 MAGGENOME TECHNOLOGIES PVT. LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 MEDOX BIOTECH INDIA PVT. LTD.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 MERIDIAN BIOSCIENCE, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 NEW ENGLAND BIOLABS
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 NORGEN BIOTEK CORP.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 OMEGA BIO-TEK, INC.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PCR BIOSYSTEMS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 PERKINELMER
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 PROMEGA CORPORATION
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 QIAGEN
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENTS/NEWS
16.25 SAGE SCIENCE, INC.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENTS
16.26 TAKARA BIO INC.
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
16.28 TIANGEN BIOTECH (BEIJING) CO.,LTD.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY CO., LTD
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
16.3 ZYMO RESEARCH CORPORATION
16.30.1 COMPANY SNAPSHOT
16.30.2 PRODUCT PORTFOLIO
16.30.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 NORTH AMERICA GENOMIC DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 4 NORTH AMERICA TOTAL RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 5 NORTH AMERICA PCR CLEAN-UP IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 NORTH AMERICA PLASMID DNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 7 NORTH AMERICA MESSENGER RNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 NORTH AMERICA CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 9 NORTH AMERICA MICRORNA ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 12 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 13 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 15 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 16 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 17 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 18 NORTH AMERICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 NORTH AMERICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 NORTH AMERICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 23 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 24 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 25 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 26 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 27 NORTH AMERICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 30 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 31 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 33 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 34 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 36 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 37 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 40 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 41 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 NORTH AMERICA FFPE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 NORTH AMERICA BLOOD CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 NORTH AMERICA BACTERIA, YEAST, AND PLANTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 45 NORTH AMERICA CELL-FREE SAMPLES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 NORTH AMERICA CULTURED CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 NORTH AMERICA MAMMALIAN CELLS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 NORTH AMERICA BRAIN AND KIDNEY TISSUE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 49 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 51 NORTH AMERICA MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 NORTH AMERICA COLUMN-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 53 NORTH AMERICA REAGENT-BASED ISOLATION AND PURIFICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 56 NORTH AMERICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 57 NORTH AMERICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 NORTH AMERICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 NORTH AMERICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 NORTH AMERICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 63 NORTH AMERICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 65 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 66 NORTH AMERICA HOSPITALS AND DIAGNOSTIC CENTERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 67 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 68 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 69 NORTH AMERICA CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 70 NORTH AMERICA ACADEMIC/RESEARCH INSTITUTES IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 71 NORTH AMERICA OTHERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 72 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 73 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 74 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 77 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 78 NORTH AMERICA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 79 NORTH AMERICA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 NORTH AMERICA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 83 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 84 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 86 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 87 NORTH AMERICA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 90 NORTH AMERICA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 91 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 93 NORTH AMERICA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 94 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 96 NORTH AMERICA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 97 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 99 NORTH AMERICA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 100 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 101 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 103 NORTH AMERICA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 NORTH AMERICA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 NORTH AMERICA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 109 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 110 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 112 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 113 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 114 U.S. INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 115 U.S. KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 U.S. DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 120 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 122 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 123 U.S. RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 U.S. MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 127 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 129 U.S. COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 130 U.S. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 U.S. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 132 U.S. VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 133 U.S. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 U.S. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 135 U.S. REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 136 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 137 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 139 U.S. DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 U.S. DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 U.S. PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 U.S. AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 U.S. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 145 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 146 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 148 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 149 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 150 CANADA INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 151 CANADA KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 CANADA DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 155 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 156 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 158 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 159 CANADA RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 160 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 162 CANADA MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 163 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 165 CANADA COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 166 CANADA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 CANADA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 168 CANADA VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 169 CANADA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 CANADA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 171 CANADA REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 172 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 173 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 175 CANADA DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 CANADA DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 CANADA PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 CANADA AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 180 CANADA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 181 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 182 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 184 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 185 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 186 MEXICO INSTRUMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY USABILITY, 2018-2032 (USD THOUSAND)
TABLE 187 MEXICO KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 MEXICO DNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 189 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 191 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 192 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 193 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 194 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 195 MEXICO RNA ISOLATION & PURIFICATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 198 MEXICO MAGNETIC BEAD-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 199 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 201 MEXICO COLUMN-BASED KIT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 202 MEXICO VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 203 MEXICO VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 204 MEXICO VIRAL NUCLEIC ACID ISOLATION KITS IN NUCLEIC ACID ISOLATION, BY TYPE, 2018-2032 (ASP)
TABLE 205 MEXICO REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 206 MEXICO REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 207 MEXICO REAGENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (ASP)
TABLE 208 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2032 (USD THOUSAND)
TABLE 209 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 211 MEXICO DIAGNOSTICS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 MEXICO DRUG DISCOVERY AND DEVELOPMENT IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 MEXICO PERSONALIZED MEDICINE IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 MEXICO AGRICULTURE AND ANIMAL RESEARCH IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2032 (USD THOUSAND)
그림 목록
FIGURE 1 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 LINE CHART, BY PRODUCT (2024)
FIGURE 15 THREE SEGMENTS COMPRISE THE NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2024)
FIGURE 16 INCREASING PREVALENCE OF GENETIC DISORDERS IS EXPECTED TO DRIVE THE NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN THE FORECAST PERIOD (2025-2032)
FIGURE 17 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2025 & 2032
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 19 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY AGE GROUP (AGES 0–17)
FIGURE 20 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY GENDER
FIGURE 21 DISTRIBUTION OF REPORTED GENETIC CONDITIONS AMONG CHILDREN BY RACE AND ETHNICITY
FIGURE 22 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2024
FIGURE 23 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 24 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 25 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2024
FIGURE 27 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, 2025-2032 (USD THOUSAND)
FIGURE 28 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, CAGR (2025-2032)
FIGURE 29 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 30 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2024
FIGURE 31 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, 2025-2032 (USD THOUSAND)
FIGURE 32 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, CAGR (2025-2032)
FIGURE 33 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 34 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2024
FIGURE 35 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, 2025-2032 (USD THOUSAND)
FIGURE 36 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, CAGR (2025-2032)
FIGURE 37 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY METHOD, LIFELINE CURVE
FIGURE 38 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2024
FIGURE 39 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, 2025-2032 (USD THOUSAND)
FIGURE 40 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, CAGR (2025-2032)
FIGURE 41 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 42 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2024
FIGURE 43 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 44 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, CAGR (2025-2032)
FIGURE 45 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 46 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SNAPSHOT (2024)
FIGURE 47 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY SHARE 2024 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
